ICU (SeaStar Medical Holding) 3-Year Revenue Growth Rate : 0.00% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is SeaStar Medical Holding 3-Year Revenue Growth Rate?

SeaStar Medical Holding's Revenue per Share for the three months ended in Sep. 2024 was $0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Competitive Comparison of SeaStar Medical Holding's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, SeaStar Medical Holding's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SeaStar Medical Holding's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SeaStar Medical Holding's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where SeaStar Medical Holding's 3-Year Revenue Growth Rate falls into.

SeaStar Medical Holding 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

SeaStar Medical Holding (NAS:ICU) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

SeaStar Medical Holding 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of SeaStar Medical Holding's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

SeaStar Medical Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SeaStar Medical Holding Corp (NAS:ICU) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

3513 Brighton Boulevard, Suite 410, Denver, CO, USA, 80216

Website

https://www.seastarmedical.com

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Executives

Kevin Chung	officer: Chief Medical Officer	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Heel Kenneth Van	director	C/O PFENEX INC., 10790 ROSELLE STREET, SAN DIEGO CA 92121
Richard D. Russell	director	3201 W BAY VISTA AVE, TAMPA FL 33611
Bruce M. Rodgers	director	302 KNIGHTS RUN AVE., STE. 1000, TAMPA FL 33602
Andres Lobo	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Caryl Baron	officer: See Remarks	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Eric Schlorff	director, officer: Chief Executive Officer	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Rick Barnett	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Allan Collins	director	C/O SEASTAR MEDICAL, INC., 3513 BRIGHTON BOULEVARD, SUITE 410, DENVER CO 80216
Dow Employees' Pension Plan Trust	10 percent owner	2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Union Carbide Employees' Pension Plan Trust	10 percent owner	2211 H.H. DOW WAY, SSC BUILDING, MIDLAND MI 48674
Martin A Traber	director	100 N TAMPA STREET, SUITE 2700, TAMPA FL 33602
Lm Funding America, Inc.	10 percent owner	1200 WEST PLATT STREET, SUITE 100, TAMPA FL 33606
Craig E Burson	director	400 N. PARK AVENUE, UNIT 10B, BRECKENRIDGE CO 80424
Bruce H Bennett	director	3929 ARLINGTON DRIVE, PALM HARBOR FL 34685